Literature DB >> 27034122

The relation between oxidative stress biomarkers and atrial fibrillation after pulmonary veins isolation.

A Böhm1, L Tothova2, L Urban3, P Slezak4, L Bacharova5, P Musil6, R Hatala7.   

Abstract

INTRODUCTION: The current paradigm claims a link between oxidative stress and atrial fibrillation. The aim of our research was to study a relation between the percentage of time spent in atrial fibrillation (AF burden) and concentrations of oxidative stress biomarkers, before and after pulmonary veins isolation (PVI).
METHODOLOGY: We included 19 patients (mean age 55±10years, 4 females and 15 males) with implanted loop recorders undergoing PVI. Plasmatic concentrations of advanced glycation end-products (AGEs), fructosamine, advanced oxidation protein products and thiobarbituric-acid reacting substances (TBARS) were measured and AF burden was recorded immediately before and 3months after the PVI. AF burden was also recorded 9months after the PVI.
RESULTS: Post procedural AGEs concentration significantly negatively correlated with AF burden after 3months (ρ=-0.63; p<0.01) and 9months (ρ=-0.5; p=0.04), respectively as well as TBARS concentration significantly negatively correlated with AF burden after 9months (ρ=-0.61; p=0.01).
CONCLUSION: Our study showed AGEs and TBARS to be potential predictors for AF burden after the PVI. We suppose that the more oxidative stress after the PVI is provoked, the more fibrotic tissue is produced. That means a better electrical isolation of pulmonary veins and consequently a lower AF burden.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Implantable loop recorder; Oxidative stress biomarkers; Radiofrequency catheter ablation

Mesh:

Substances:

Year:  2016        PMID: 27034122     DOI: 10.1016/j.jelectrocard.2016.03.007

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  4 in total

Review 1.  Molecular Mechanisms, Diagnostic Aspects and Therapeutic Opportunities of Micro Ribonucleic Acids in Atrial Fibrillation.

Authors:  Allan Böhm; Marianna Vachalcova; Peter Snopek; Ljuba Bacharova; Dominika Komarova; Robert Hatala
Journal:  Int J Mol Sci       Date:  2020-04-15       Impact factor: 5.923

Review 2.  Mitochondrial and Sarcoplasmic Reticulum Interconnection in Cardiac Arrhythmia.

Authors:  Felipe Salazar-Ramírez; Roberto Ramos-Mondragón; Gerardo García-Rivas
Journal:  Front Cell Dev Biol       Date:  2021-01-28

3.  Advanced glycation end products predict long-term outcome of catheter ablation in paroxysmal atrial fibrillation.

Authors:  Allan Bohm; Lubos Urban; Lubomira Tothova; Ljuba Bacharova; Peter Musil; Jan Kyselovic; Peter Michalek; Tomas Uher; Branislav Bezak; Peter Olejnik; Robert Hatala
Journal:  J Interv Card Electrophysiol       Date:  2021-03-10       Impact factor: 1.900

Review 4.  Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.

Authors:  David Bode; Lukas Semmler; Christian U Oeing; Alessio Alogna; Gabriele G Schiattarella; Burkert M Pieske; Frank R Heinzel; Felix Hohendanner
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.